The top medical advances of 2025
statnews.com••health
Key Points:
- In 2025, significant medical advances occurred despite political challenges, including a groundbreaking CRISPR gene-editing treatment for a baby with a rare liver disease, highlighting the potential for personalized "n of 1" therapies.
- The FDA approved 44 new drugs this year, including Gilead’s Yeztugo for HIV prevention, Vertex’s non-opioid painkiller Journavx, and two new antibiotics for gonorrhea, addressing critical public health needs.
- Progress in cancer treatment continued with five new lung cancer drugs approved, including targeted therapies like Rybrevant and Enhertu, which extend patient survival and delay tumor progression.
- Vaccination advances showed promising broader impacts, such as shingles vaccines potentially reducing Alzheimer’s risk and HPV
